Publication
Article
Supplements and Featured Publications
Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care PerspectiveVolume8 Issue 17 Suppl
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
Author(s):
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
